Skip to content

Fracture Risk Evaluation of Bone Metastases Derived From Carcinoma

Generation of Synthetic Patient Data (RAW) for Risk Evaluation of Bone Metastases Derived From Carcinoma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06524843
Enrollment
250
Registered
2024-07-29
Start date
2024-09-23
Completion date
2026-12-31
Last updated
2025-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone Metastases

Keywords

Bone metastases, Prediction model

Brief summary

From the archives of the Rizzoli institute all patients (approximately 750) treated for bone metastases from 01/01/2010 to 31/12/2022. A review will be made from the medical records, radiological imaging, and histological data of these patients

Interventions

Analysis and review of imaging and clinical data

Sponsors

Costantino Errani
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 years * Diagnosis of bone metastasis from carcinoma, regardless of the type of carcinoma, and of the number and location of the metastases * Availability of imaging and clinical data * Availability of at least one follow-up during the last 12 months form diagnosis

Exclusion criteria

* At least one inclusion creteria not met

Design outcomes

Primary

MeasureTime frameDescription
Creation a dataset of clinical data and diagnostic imagesAt baseline (Day 0)Creation a dataset of clinical data and diagnostic images, called RAW, relating to patients suffering from metastatic bone cancer that will be used by the unit UNICH to create innovative models for fracture risk prediction and of life expectancy based on various patient clinical parameters.

Countries

Italy

Contacts

Primary ContactCostantino Errani, MD
costantino.errani@ior.it0516366
Backup ContactRoberta Laranga, PhD
roberta.laranga@ior.it051636

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026